Company Overview

Development Stage

About the Company

[Summary] 一家拥有70余年辉煌历史的制药企业

华润双鹤药业股份有限公司拥有78年光辉历史,经历了中国制药业数次历史性变迁。1939年作为部队药厂诞生太行;1949年迁至北京后更名北京制药厂,逐渐发展为化学药综合制剂企业,奠定北京现代化学制药工业基础;1997年在上交所上市,通过外延扩张成为立足北京、辐射全国的跨地域集团;2010年随着原股东北京医药集团进入华润集团旗下,2012年更名为华润双鹤药业股份有限公司,成为华润集团医药板块化学药平台支柱企业。公司拥有16家子公司,近14000名员工,主营业务涵盖新药研发、制剂生产、医药销售、制药装备及原料药生产等方面,具有丰富的产品线和品牌优势、优质的产品质量、渠道与终端的覆盖与管理能力、国际化优势等核心竞争力,经济实力、竞争活力和可持续发展能力位居国内制药公司前列。公司搭建了慢病普药业务、专科业务、输液业务三大业务平台,拥有〇号、冠爽、糖适平、珂立苏、压氏达等10个知名超亿元产品,先后荣获“高新技术企业”、“中国化学制药行业工业企业综合实力百强”、“企业信用评价AAA级企业”等多项荣誉。2016年,公司实现主营业务收入53.67亿元,净利润(归属母公司)7.14亿元。公司具备较好的研发实力,大力推动产品获得,搭建多个生产技术平台,积极与国外药企合作,为市场提供更多的产品选择;17家生产基地分布在我国东北、华北、西北、华东、华南等地,生产管理体系先进,质量标准国际化,为数千万患者提供安全有效的健康支持;营销网络遍布全国,通过丰富的产品支持、贴心周到的营销服务、良好的终端掌控能力和专业化的销售团队,与客户携手共赢。十三五战略期间,公司确立打造百亿工业目标,秉承“关心大众,健康民生”的企业使命,致力成为*的制药企业,在非输液领域引领专科发展创新。发展扩大国内先进的慢病管理平台;在输液领域全国领先的综合性输液企业,为病患提供治疗和能量补充解决方案,为人类健康事业和中国医药行业的发展做出更大贡献。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

华润双鹤 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

华润双鹤 How Fast Is Hiring Growing? (652 open positions)

Manage
Note: How fast is hiring at 华润双鹤药业股份有限公司 growing? 华润双鹤2026: 1082 openings (up 57%), 2025: 690 openings (up 46%), 2024: 471 openings (up 82%), 2023: 259 openings (up 114%), 2022: 121 openings (down 72%), 2021: 434 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

华润双鹤 Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at 华润双鹤药业股份有限公司 growing? 华润双鹤Master's recruitment over the years: 2025: 40 openings (up 8%), 2024: 37 openings (up 9%), 2023: 34 openings (down 3%), 2022: 35 openings (up 192%), 2021: 12 openings.

华润双鹤 Doctoral Degree Job Demand Analysis

(More)
+300%
Growth Rate
2026 vs 2025
  • 2025: Up 33%
  • 2024: Down 86%
  • 2023: Up 120%
华润双鹤 Doctoral Hiring by Year: 2026 — 12 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 华润双鹤药业股份有限公司 growing? 华润双鹤Doctorate recruitment over the years: 2026: 16 openings (up 300%), 2025: 4 openings (up 33%), 2024: 3 openings (down 86%), 2023: 22 openings (up 120%), 2022: 10 openings.

华润双鹤 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 华润双鹤药业股份有限公司? Based on an analysis of 华润双鹤's job postings over the past year, "医疗卫生/美容保健类" demand: 26.2%, "计算机/网络/技术类": 9.1%, "生物/制药/化工/环保类": 9%, "其他(研发和技术类)": 3.7%, "科研类": 2.1%, "机械/仪器仪表类": 1.6%. For reference only.

华润双鹤 — What Are the Salaries Like? (1240 records)

Manage
salary range: 4.5K - 50K, 51% of roles pay ¥8-15K
Note: salary statistics are based on 1240 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 华润双鹤药业股份有限公司?华润双鹤51% of positions earn 8-15K, Fresh graduate salary: ¥6.3K。销售类 average salary ¥12.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 华润双鹤

(More)
Are salaries high at 华润双鹤药业股份有限公司? We provide: 医药代表,临床,销售,招商,信息,推广,ka,市场,运营,零售,产品经理,药学,质量,otc代表,分析,儿科,管培生,qa,财务,研究员. Click to view detailed salary analysis by job.

华润双鹤 — Fortune 500? (More)

Yes, ranked in 中国乡村振兴企业500强:

Yes, ranked in 中国企业慈善公益500强:

华润双鹤 Related Industry Tags

Job Category

  • 销售类
    59.5% of total 59.5%
  • 医疗卫生/美容保健类
    25.2% of total 25.2%
  • 经营管理类
    18.9% of total 18.9%
  • 市场/公关/媒介类
    13% of total 13%

Education

  • 本科
    46.3% of total 46.3%
  • 大专
    38.2% of total 38.2%
  • 硕士
    5.5% of total 5.5%
  • 高中
    4.4% of total 4.4%

Experience

  • 1-3年
    45.1% of total 45.1%
  • 不限
    23% of total 23%
  • 3-5年
    22.1% of total 22.1%
  • 5-10年
    8.7% of total 8.7%
View Detailed Analysis

What does 华润双鹤药业股份有限公司 require? Who is 华润双鹤 hiring? 华润双鹤 recruitment: 销售类占比最多占59.5%,其次是医疗卫生/美容保健类占25.2%. What education can get in at 华润双鹤? 本科占比最多占46.3%,其次是大专占38.2%. High education required at 华润双鹤? 硕士占5.5%,博士占1.3%. Work experience required at 华润双鹤? 1-3年占比最多占45.1%,其次是不限占23%. Where are the job locations at 华润双鹤? 北京占比最多占25.4%,其次是济南占5.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 103,875.7509万(元)
Legal Representative: 赵骞
Date Established:
Credit Code: 91110000633796475U
Registered Address: 北京市朝阳区望京利泽东二路1号

Partners & Suppliers

为华润双鹤提供临床试验CRO服务 Source
供应商 制药企业
签署战略合作协议,在市场开发、产品代理等方面协同合作 Source
供应商 医药工业
在药品研发、生产、销售等方面加深合作 Source
合作客户 药企战略合作
北京双鹤药业经营有限责任公司作为华润双鹤的医药商业平台,持续采购华润双鹤生产的药品进行分销。 Source
合作客户 药品采购
华润双鹤长期采购上海诺狄的微生物快速检测系统,用于生产车间的微生物限度检测。 Source
供应商 制药行业客户

People who follow 华润双鹤 also follow

华润双鹤 Competitors (Similar Companies)

“Large-scale pharmaceutical distribution enterprise”
“Large pharmaceutical group”
“Although the processing is complicated, we dare not save labor; althou”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Caring for Public Health, Creating a Better Life Together”
制药/药业 医药 新药研发 医药工业
“Caring for life, safeguarding health”
医药工业 医药
“Research, development, and production of anti-tumor and surgical medic”
“A leader in China's pharmaceutical and healthcare market”
“One of China's Top 20 Listed Pharmaceutical Companies”
“New energy vehicle manufacturer”
“Adhering to the corporate culture of science and excellence, committed”
“Providing first-class solutions for global new energy applications”
“Large pharmaceutical and health industry group”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates